A Comprehensive Handbook for Pharmaceutical Patent Litigation Funding and Alternative Fee Arrangements

October 25, 2023 2:30pm

Ryan M. Daniel
VP, Associate General Counsel, Corporate and Business Transactions
Biopharmaceuticals

Fresenius Kabi, LLC

Kevin Nelson
Partner
ArentFox Schiff LLP

Justin A. Maleson
Director
Longford Capital Management LP

Litigation funding can help businesses pay for legal fees and expenses, including increasingly costly expert fees. Alternative fee arrangements can provide risk averse litigants with the confidence to see cases through to their conclusion, even against the best-capitalized defendants. In this interactive practical session, topics of discussion will include:

  • Reviewing litigation funding and other alternative fee arrangements and the advantages for litigants
  • Assessing risk-sharing solutions to provide better predictability and value
  • Recognizing the essential criteria of a feasible funding opportunity based on meritorious claims
  • Analyzing the mechanics of the financer’s underwriting process
  • Exploring the key modules of a pharmaceutical patent litigation funding agreement